References
- Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288–291.
- Preble JM, Silpa-archa S, Foster CS. Ocular involvement in systemic lupus erythematosus. CurrOpinOphthalmol. 2015;26(6):540–545. doi:10.1097/ICU.0000000000000209.
- Fraga MM, Len CA, Dos Santos Finamor LP, et al. Ocular changes due to the treatment of juvenile systemic lupus erythematosus. Rev Bras Reumatol. 2011;51(6):554–557. doi:10.1590/S0482-50042011000600003.
- Ağın A, Kadayıfçılar S, Sönmez HE, et al. Evaluation of choroidal thickness, choroidal vascularity index and peripapillary retinal nerve fiber layer in patients with juvenile systemic lupus erythematosus. Lupus. 2019;28(1):44–50. doi:10.1177/0961203318814196.
- Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1–55. doi:10.1016/j.preteyeres.2017.11.003.
- Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686. doi:10.1002/art.34473.
- Pichi F, Sarraf D, Arepalli S, et al. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res. 2017;59:178–201. doi:10.1016/j.preteyeres.2017.04.005.
- Forte R, Haulani H, Dyrda A, Jürgens I. Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests. Br J Ophthalmol. 2021;105(9):1297–1301. doi:10.1136/bjophthalmol-2018-313679.
- Mihailovic N, Leclaire MD, Eter N, Brücher VC. Altered microvascular density in patients with systemic lupus erythematosus treated with hydroxychloroquine-an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol. 2020;258(10):2263–2269. doi:10.1007/s00417-020-04788-4.
- Arfeen SA, Bahgat N, Adel N, Eissa M, Khafagy MM. Assessment of superficial and deep retinal vessel density in systemic lupus erythematosus patients using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1261–1268. doi:10.1007/s00417-020-04626-7.
- Işık MU, Akmaz B, Akay F, et al. Evaluation of subclinical retinopathy and angiopathy with OCT and OCTA in patients with systemic lupus erythematosus. Int Ophthalmol. 2021;41(1):143–150. doi:10.1007/s10792-020-01561-8.
- Ermurat S, Koyuncu K. Evaluation of subclinical retinal microvascular changes in systemic lupus erythematosus patients using optical coherence tomography angiography and its relationship with disease activity. Lupus. 2022;31(5):541–554. doi:10.1177/09612033221084222.
- An Q, Gao J, Liu L, Liao R, Shuai Z. Analysis of foveal microvascular abnormalities in patients with systemic lupus erythematosus using optical coherence tomography angiography. Ocul Immunol Inflamm. 2021;29(7–8):1392–1397. doi:10.1080/09273948.2020.1735452.
- Shi WQ, Han T, Liu R, et al. Retinal microvasculature and conjunctival vessel alterations in patients with systemic lupus erythematosus-an optical coherence tomography angiography study. Front Med (Lausanne). 2021. 8:724283. Published 2021 Dec 2. doi:10.3389/fmed.2021.724283.
- Liu R, Wang Y, Xia Q, et al. Retinal thickness and microvascular alterations in the diagnosis of systemic lupus erythematosus: a new approach. Quant Imaging Med Surg. 2022;12(1):823–837. doi:10.21037/qims-21-359.
- Conigliaro P, Cesareo M, Chimenti MS, et al. Evaluation of retinal microvascular density in patients affected by systemic lupus erythematosus: an optical coherence tomography angiography study. Ann Rheum Dis. 2019;78(2):287–289. doi:10.1136/annrheumdis-2018-214235.
- Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135–149. doi:10.1007/s10238-017-0479-9.
- Barile-Fabris L, Hernández-Cabrera MF, Barragan-Garfias JA. Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep. 2014;16(9):440. doi:10.1007/s11926-014-0440-9.
- Karpik AG, Schwartz MM, Dickey LE, Streeten BW, Roberts JL. Ocular immune reactants in patients dying with systemic lupus erythematosus. Clin Immunol Immunopathol. 1985;35(3):295–312. doi:10.1016/0090-1229(85)90091-1.
- Gawdat G, El-Fayoumi D, Marzouk H, Farag Y. Ocular manifestations in children with juvenile-onset systemic lupus erythematosus. Semin Ophthalmol. 2018;33(4):470–476. doi:10.1080/08820538.2017.1301497.
- Coscas F, Glacet-Bernard A, Miere A, et al. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Am J Ophthalmol. 2016;161:160–71.e712. doi:10.1016/j.ajo.2015.10.008.
- YılmazTuğan B, Sönmez HE. Optical coherence tomography angiography of subclinical ocular features in pediatric Behçet disease. J AAPOS. 2022;26(1):24.e1–24.e6. doi:10.1016/j.jaapos.2021.10.004.
- Bonnin S, Mané V, Couturier A, et al. New insight into the macular deep vascular plexus imaged by optical coherence tomography angiography. Retina. 2015;35(11):2347–2352. doi:10.1097/IAE.0000000000000839.
- Simonett JM, Scarinci F, Picconi F, et al. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus. Acta Ophthalmol. 2017;95(8):e751–e755. doi:10.1111/aos.13404.
- Nesper PL, Scarinci F, Fawzi AA. Adaptive optics reveals photoreceptor abnormalities in diabetic macular ischemia. PLoS One. 2017;12(1):e0169926. Published 2017 Jan 9. doi:10.1371/journal.pone.0169926.
- Bates NM, Tian J, Smiddy WE, et al. Relationship between the morphology of the foveal avascular zone, retinal structure, and macular circulation in patients with diabetes mellitus. Sci Rep. 2018; 8(1):5355. Published 2018 Mar 29. doi:10.1038/s41598-018-23604-y.
- Roemer S, Bergin C, Kaeser PF, Ambresin A. Assessment of macular vasculature of children with sickle cell disease compared to that of healthy controls using optical coherence tomography angiography. Retina. 2019;39(12):2384–2391. doi:10.1097/IAE.0000000000002321.
- DeWitt EM, Schanberg LS, Rabinovich CE. Treatment of rheumaric diseases. In: Kleigman RM, Stanton BF, Geme JWS, Schor NF, Behrman RE, eds. Nelson Textbook of Paediatrics. 19th ed. Philadelphia, PA: Elsevier; 2012:841–846.
- Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. American academy of ophthalmology. recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123(6):1386–1394. doi:10.1016/j.ophtha.2016.01.058.
- Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy [published correction appears in JAMA Ophthalmol. 2014 Dec;132(12):1493. JAMA Ophthalmol. 2014;132(12):1453–1460. doi:10.1001/jamaophthalmol.2014.3459.